Answers are grounded in this paper and cite their sources.
This review highlights orphan cannabinoid receptors GPR18, GPR55, and GPR119, indicating their limited activation evidence in vivo.
GPR18, GPR55 and GPR119 (provisional nomenclature), although showing little structural similarity to CB1 and CB2 cannabinoid receptors, respond to endogenous agents analogous to the endogenous cannabinoid ligands, as well as some natural/synthetic cannabinoid receptor ligands [105]. Although there are multiple reports to indicate that GPR18, GPR55 and GPR119 can be activated in vitro by N-arachidonoylglycine, lysophosphatidylinositol and N-oleoylethanolamide, respectively, there is a lack of evidence for activation by these lipid messengers in vivo. As such, therefore, these receptors retain their orphan status.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: